World Cervical Cancer Elimination Day: A Global Push for a Preventable Disease
Today marks a pivotal moment in global health: the inaugural World Cervical Cancer Elimination Day. This landmark occasion, mandated by the World Health Assembly, signifies a renewed and intensified commitment to eradicating a cancer that needlessly claims hundreds of thousands of lives annually. The day isn’t merely symbolic; it’s a catalyst for accelerated action, uniting nations and organizations in a concerted effort to expand vaccination programs, bolster screening initiatives, and enhance treatment access.
Cervical cancer remains the fourth most prevalent cancer affecting women worldwide, responsible for over 350,000 deaths each year. Yet, unlike many cancers, cervical cancer is largely preventable. The tools to eliminate this disease exist – and are increasingly within reach – making this a uniquely hopeful moment in public health history.
The 90-70-90 Strategy: A Roadmap to Elimination
The World Health Organization (WHO) has outlined a comprehensive global strategy centered around three ambitious targets: vaccinating 90% of girls against the human papillomavirus (HPV) – the primary cause of cervical cancer – screening 70% of women, and ensuring that 90% of those diagnosed with pre-cancerous lesions or invasive cancer receive effective treatment. This 90-70-90 framework provides a clear, measurable path toward a future free from the burden of cervical cancer.
“In 2018, I was proud to launch the global call to action on cervical cancer elimination, and I’m even prouder now to see what was once a distant dream becoming a reality,” stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. “More and more countries are scaling up HPV vaccination, improving screening, and expanding treatment, bringing us closer to a future free of cervical cancer.”
The momentum behind this initiative is substantial. Gavi, the Vaccine Alliance, and its partners have reportedly met their ambitious goal of reaching 86 million girls with HPV vaccination by the end of 2025. This achievement underscores a growing global commitment to preventative healthcare and demonstrates the power of collaborative action.
Global Action in Motion: Country-Level Initiatives
Across the globe, countries are translating this commitment into tangible action. Sierra Leone and Liberia are launching large-scale vaccination campaigns targeting over 1.5 million girls. Sierra Leone is also implementing a nationwide screening program across all 16 districts, coupled with community awareness initiatives. In Malaysia, cervical cancer survivors are leading a week-long campaign promoting self-sampling HPV testing, a crucial innovation for expanding screening accessibility.
But what are the biggest hurdles to achieving widespread cervical cancer elimination? And how can we ensure equitable access to these life-saving interventions for all women and girls, regardless of their geographic location or socioeconomic status?
Here’s a snapshot of recent progress in key regions:
- Angola: Initiated an HPV vaccination campaign in October for girls aged 9–12 years.
- China: Integrated the HPV vaccine into its national immunization program, extending vaccination coverage to all 13-year-old girls.
- Cuba: Launched HPV vaccination in October 2025 for all girls in Grade 4.
- Ghana: Conducted a nationwide vaccination campaign in October 2025, aiming to reach 2.4 million girls aged 9–14 years.
- Indonesia: Hosted the Second Global Forum for Cervical Cancer Elimination and reaffirmed its commitment to elimination by 2030, guided by its National Cervical Cancer Elimination Plan 2023–2030.
- Nepal: Implemented a nationwide HPV vaccination campaign targeting girls aged 10–14 years in February 2025, marking the vaccine’s inclusion in the national immunization schedule.
- Nigeria: Launched a nationwide elimination effort, bolstered by a US$700,000 commitment from First Lady Senator Oluremi Tinubu through the ‘Renewed Hope Initiative.’
- Pakistan: Undertook the largest single HPV campaign to date, reaching over 9 million girls aged 9–14.
- Rwanda: Through Mission 2027 and its Accelerated Plan for Elimination, is rapidly expanding screening and treatment services to meet the 90-70-90 targets by 2027.
- Spain: Through the Spanish Agency for International Development Cooperation (AECID), is supporting the WHO Cervical Cancer Elimination Initiative in the African and Eastern Mediterranean Regions.
- South Africa: Has championed cervical cancer elimination on the G20 health agenda and is finalizing its National Strategic Framework for Cervical Cancer Elimination.
- Tajikistan: Launched HPV vaccination for all girls aged 10–14 years in its routine immunization schedule from October 2025.
- Tunisia: Introduced the HPV vaccine into its routine immunization program for 12-year-old girls in April 2025.
- WHO Western Pacific Region: Unitaid and WHO are collaborating to strengthen prevention and treatment programs, ensuring equitable access to screening and treatment.
Frequently Asked Questions About Cervical Cancer Elimination
What is HPV and how does it relate to cervical cancer?
Human papillomavirus (HPV) is a common virus that can cause various cancers, including cervical cancer. Most sexually active people will get HPV at some point in their lives, but most infections go away on their own. However, persistent HPV infection can lead to cell changes that can develop into cancer.
How effective is the HPV vaccine in preventing cervical cancer?
The HPV vaccine is highly effective in preventing infection with the types of HPV that cause most cervical cancers. When administered before exposure to the virus, it can provide nearly 100% protection against those specific HPV types.
What are the different screening methods available for cervical cancer?
Common screening methods include the Pap test (cytology) and HPV testing. HPV testing can detect the presence of high-risk HPV types, while the Pap test looks for abnormal cell changes. Self-sampling HPV testing is an emerging method increasing access to screening.
Is cervical cancer elimination achievable globally?
Yes, cervical cancer elimination is achievable with sustained global efforts focused on HPV vaccination, screening, and treatment. The WHO’s 90-70-90 strategy provides a clear roadmap for success.
What role do international organizations play in cervical cancer elimination?
Organizations like the WHO, Gavi, the Vaccine Alliance, and Unitaid play a crucial role in providing technical assistance, funding, and advocacy to support national cervical cancer elimination programs.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
